TAISF Taisho Pharmaceutical Holdings Co. Ltd.

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Taisho Pharmaceutical Holdings Co. Ltd. market cap is $4.65B.

52 week high is the highest price of a stock in the past 52 weeks, or one year. Taisho Pharmaceutical Holdings Co. Ltd. 52 week high is $60.00 as of July 26, 2024.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. Taisho Pharmaceutical Holdings Co. Ltd. 52 week low is $38.00 as of July 26, 2024.

Taisho Pharmaceutical Holdings Co. Ltd. stock price today is $59.00.

Taisho Pharmaceutical Holdings Co. Ltd. stock price yesterday was $59.23.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Taisho Pharmaceutical Holdings Co. Ltd.’s P/E ratio is 83.19.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Taisho Pharmaceutical Holdings Co. Ltd. P/B ratio is 0.8194.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Taisho Pharmaceutical Holdings Co. Ltd.'s EBITDA is 9.49.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Taisho Pharmaceutical Holdings Co. Ltd. 50-day moving average is $59.00.